Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Dermatology

Free Subscription Articles published in Am J Ophthalmol Retrieve available abstracts of 46 articles: HTML format

Single Articles

August 2026
1. ARSLAN GD, Alizada M, Ciftci S, Beser BG, et al
   Repeat Gene Expression Profiling, PRAME Status, and Next-Generation Sequencing Testing in Uveal Melanoma Undergoing Secondary Therapy.
   Am J Ophthalmol. 2026 Aug 25:S0002-9394(26)00485.
   PubMed     Abstract available
   
   
   
2. BOURKE L, Horgan N, Murtagh P
   Occult ciliary body melanoma masquerading as refractory glaucoma.
   Am J Ophthalmol. 2026 Aug 24:S0002-9394(26)00477.
   PubMed    
   
   
   
3. VAISMAN D, Pe'er J, Eiger-Moscovich M, Lotem M, et al
   Corrigendum to Interferon Alpha-2a as Treatment for Primary Acquired Melanosis With Atypia and for Primary Acquired Melanosis With Atypia Surrounding Conjunctival Melanoma. Am J Ophthalmol. 2026;285:318-323.
   Am J Ophthalmol. 2026 Aug 14:S0002-9394(26)00401.
   PubMed    
   
   
   July 2026
4. SHRINKHAL, Shukla A, Prasad N
   Medial Canthal Eyelid Acrochordon Presenting as a Cutaneous Horn in Young Girl.
   Am J Ophthalmol. 2026 Jul 9:S0002-9394(26)00373.
   PubMed    
   
   
   June 2026
5. KIM TY, Choi EY, Lee S, Choi YJ, et al
   Clinical Utility of Ultra-Widefield Swept-Source OCT for Intraocular Tumors: Comparison With Ultrasonography, SD-OCT, and MRI.
   Am J Ophthalmol. 2026 Jun 30:S0002-9394(26)00355.
   PubMed     Abstract available
   
   
   
6. OZBAY EK, Ozturk B, Ozbay MF, Dogan B, et al
   Corneal Epithelial Alterations Associated With CDK4/6 Inhibitor Therapy in Hormone Receptor-Positive Breast Cancer.
   Am J Ophthalmol. 2026 Jun 24:S0002-9394(26)00329.
   PubMed     Abstract available
   
   
   
7. BELLANDA V, Schulgit MJ, Hassan KA, Kennedy LB, et al
   Immune Checkpoint Inhibitor-Associated Uveitis: Insights from Comparative Analyses Across Malignancies and Drug Classes.
   Am J Ophthalmol. 2026 Jun 1:S0002-9394(26)00298.
   PubMed     Abstract available
   
   
   
8. KATE A, Wannapanich T, Huang AJW, Jhanji V, et al
   Conjunctival Biopsy in Ocular Mucous Membrane Pemphigoid.
   Am J Ophthalmol. 2026 Jun 1:S0002-9394(26)00290.
   PubMed     Abstract available
   
   
   May 2026
9. DAVE N, Taylor Gonzalez DJ, Cernichiaro-Espinosa LA, King BA, et al
   One-Year Tumor Volume Regression Predicts Survival After I-125 Plaque Brachytherapy for Posterior Uveal Melanoma.
   Am J Ophthalmol. 2026 May 12:S0002-9394(26)00239.
   PubMed     Abstract available
   
   
   
10. VAISMAN D, Pe'er J, Eiger-Moscovich M, Lotem M, et al
    Reply to comments on Interferon Alpha-2a as Treatment for Primary Acquired Melanosis with Atypia (PAMwA) and for PAMwA surrounding conjunctival melanoma.
    Am J Ophthalmol. 2026 May 9:S0002-9394(26)00226.
    PubMed    
    
    
    
11. YADAV R, Yadav V, Rastogi S
    Comment on "Interferon Alpha-2a as Treatment for Primary Acquired Melanosis With Atypia and for Primary Acquired Melanosis With Atypia Surrounding Conjunctival Melanoma".
    Am J Ophthalmol. 2026 May 2:S0002-9394(26)00225.
    PubMed    
    
    
    April 2026
12. PLACIDE J, Phan M, Tedla S, Kay PS, et al
    Ocular Symptoms Lead to Shortest Diagnostic Delay in Biopsy-Proven Giant Cell Arteritis: A Nationwide Veterans Health Study.
    Am J Ophthalmol. 2026 Apr 20:S0002-9394(26)00210.
    PubMed     Abstract available
    
    
    
13. LISHINSKY-FISCHER N, Gharra S, Nitzan I, Chowers I, et al
    Reduced Risk of Non-Neovascular AMD in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Propensity-Matched Cohort Study.
    Am J Ophthalmol. 2026;284:153-160.
    PubMed     Abstract available
    
    
    February 2026
14. SAKATA R, Shijo T, Ueno Y, Oda M, et al
    Deep learning-based diagnostic model for ocular surface neoplastic diseases.
    Am J Ophthalmol. 2026 Feb 24:S0002-9394(26)00089.
    PubMed     Abstract available
    
    
    
15. JIA H, Cai R, Liu L, Zhang J, et al
    Mismatch Repair Deficiency in Benign and Atypical Ocular Sebaceous Neoplasms: Implications for Muir-Torre Screening and Classification.
    Am J Ophthalmol. 2026 Feb 18:S0002-9394(26)00079.
    PubMed     Abstract available
    
    
    January 2026
16. VAISMAN D, Pe'er J, Eiger-Moscovich M, Lotem M, et al
    Interferon Alpha-2a as Treatment for Primary Acquired Melanosis with Atypia (PAMwA) and for PAMwA surrounding conjunctival melanoma.
    Am J Ophthalmol. 2026 Jan 29:S0002-9394(26)00042.
    PubMed     Abstract available
    
    
    
17. ESEN F, Kokoglu A, Cetin C, Turkyilmaz O, et al
    Adalimumab-induced changes in NK cells phenotype, receptors and functions after clinical remission of Behcet's uveitis.
    Am J Ophthalmol. 2026 Jan 19:S0002-9394(26)00013.
    PubMed     Abstract available
    
    
    
18. ABDELKADER MA, Salah SH, Al-Etr SF, Qadi LE, et al
    Early Peripapillary and Macular Microvascular Changes Following Ruthenium-106 Plaque Brachytherapy For Uveal Melanomas.
    Am J Ophthalmol. 2026 Jan 4:S0002-9394(26)00001.
    PubMed     Abstract available
    
    
    October 2025
19. MUNKWITZ SE, Shields C, Nicola MD, Williams BK Jr, et al
    Assessment of Sensorimotor Complications after Plaque Brachytherapy for Patients with Uveal Melanoma.
    Am J Ophthalmol. 2025 Oct 14:S0002-9394(25)00546.
    PubMed     Abstract available
    
    
    
20. CHACKO JA, Chauhan MZ, Phillips PH, Ramakrishnaiah RH, et al
    Aortic and Carotid Complications in Patients With Giant Cell Arteritis.
    Am J Ophthalmol. 2025;278:65-72.
    PubMed     Abstract available
    
    
    September 2025
21. WANG CY, Lin TY, Yu Wang T, Chi CC, et al
    Ocular comorbidities of psoriasis: A systematic review and meta-analysis of observational studies.
    Am J Ophthalmol. 2025 Sep 18:S0002-9394(25)00494.
    PubMed     Abstract available
    
    
    
22. MILLER S, Cano M, Kawalerski R, Shi MD, et al
    Elevated Lactic Acid Levels in the Aqueous Humor May Be an Indicator of Uveal Melanoma.
    Am J Ophthalmol. 2025 Sep 11:S0002-9394(25)00485.
    PubMed     Abstract available
    
    
    
23. HOLLO G, Kita Y
    Comment on "OCT and OCTA Features of Optic Disc Melanocytoma: PHOMS, Perfusion Deficits, and Association with Vision Loss".
    Am J Ophthalmol. 2025 Sep 8:S0002-9394(25)00473.
    PubMed    
    
    
    
24. ZHANG R, Dong J, Li Y, Wu H, et al
    Reply to Comment on "OCT and OCTA Features of Optic Disc Melanocytoma: PHOMS, Perfusion Deficits, and Epiretinal Membrane".
    Am J Ophthalmol. 2025 Sep 5:S0002-9394(25)00474.
    PubMed    
    
    
    August 2025
25. ZHANG R, Dong J, Li Y, Wu H, et al
    OCT and OCTA Features of Optic Disc Melanocytoma: PHOMS, Perfusion Deficits, and Association with Vision Loss.
    Am J Ophthalmol. 2025 Aug 20:S0002-9394(25)00450.
    PubMed     Abstract available
    
    
    July 2025
26. KADAKIA AB, Ali AM, Chuang AZ, Schefler AC, et al
    Comparison of Patients with Observed High-Risk Choroidal Nevi That Evolved into Melanomas vs. Patients with Immediately Treated Uveal Melanomas.
    Am J Ophthalmol. 2025 Jul 2:S0002-9394(25)00347.
    PubMed     Abstract available
    
    
    
27. CASTILLEJO BECERRA CM, Crowson CS, Langenfeld HE, Tajfirouz D, et al
    Population-Based Performance of Inflammatory Markers in Giant Cell Arteritis.
    Am J Ophthalmol. 2025;275:47-51.
    PubMed     Abstract available
    
    
    May 2025
28. CHOU HD, Heimann H, Damato BE, Hussain RN, et al
    Inadvertent Scleral Perforation During Choroidal Melanoma Surgeries: Incidence, Risk Factors, Management, and Outcomes: Scleral Perforation in Melanoma Surgery.
    Am J Ophthalmol. 2025 May 31:S0002-9394(25)00278.
    PubMed     Abstract available
    
    
    
29. NITZAN I, Shemesh N, Kubovsky S, Shalmov T, et al
    Incidence of Giant Cell Arteritis Following Herpes Zoster Ophthalmicus: A Multicenter Retrospective Cohort Study.
    Am J Ophthalmol. 2025 May 23:S0002-9394(25)00251.
    PubMed     Abstract available
    
    
    March 2025
30. MUKIT FA, Terfloth N, Kim IK, Wu F, et al
    Malignant transformation of ocular melanocytoma to uveal melanoma: a clinicopathologic review of three novel unsuspected cases of a likely under-recognized phenomenon, with review of the literature and molecular genetic data.
    Am J Ophthalmol. 2025 Mar 31:S0002-9394(25)00164.
    PubMed     Abstract available
    
    
    
31. WANG C, Gu J
    Giant Conjunctival Melanoma.
    Am J Ophthalmol. 2025 Mar 27:S0002-9394(25)00156.
    PubMed    
    
    
    
32. QUIGLEY C, Pietris J, Ang T, Zgaga L, et al
    Ocular features of VEXAS syndrome: a systematic review and meta-analysis.
    Am J Ophthalmol. 2025 Mar 27:S0002-9394(25)00153.
    PubMed     Abstract available
    
    
    
33. NISSEN K, Kiilgaard JF, Fili M, Seregard S, et al
    Increasing Incidence of Posterior Uveal Melanoma in Scandinavia 1960-2022: A Tri-National Study.
    Am J Ophthalmol. 2025 Mar 5:S0002-9394(25)00115.
    PubMed     Abstract available
    
    
    February 2025
34. JANMOHAMED IK, Salam MAU, Jamall O, Elgharably M, et al
    Faricimab-Associated Intraocular Inflammation with Features of Herpes Simplex Virus.
    Am J Ophthalmol. 2025 Feb 25:S0002-9394(25)00096.
    PubMed     Abstract available
    
    
    December 2024
35. CAPPELLI L, Khan MM, Shields CL, Lally SE, et al
    Favorable outcomes of patients with high-risk uveal melanoma treated with a novel LINAC-based frameless fractionated stereotactic radiosurgery.
    Am J Ophthalmol. 2024 Dec 18:S0002-9394(24)00564.
    PubMed     Abstract available
    
    
    October 2024
36. TIAN H, Shi H, Chen J, Zhu T, et al
    Circulating tumor DNA in conjunctival melanoma: landscape and surveillance value.
    Am J Ophthalmol. 2024 Oct 16:S0002-9394(24)00479.
    PubMed     Abstract available
    
    
    
37. LAI WY, Demer JL
    Cutaneous Lower Eyelid Retractor Release Averts Lower Lid Malposition After Inferior Rectus Muscle Recession.
    Am J Ophthalmol. 2024 Oct 9:S0002-9394(24)00460.
    PubMed     Abstract available
    
    
    
38. ZHANG MG, Gallo RA, Tan CH, Camacho M, et al
    Single-cell RNA profiling of ocular adnexal sebaceous carcinoma reveals a complex tumor microenvironment and identifies new biomarkers.
    Am J Ophthalmol. 2024 Oct 9:S0002-9394(24)00471.
    PubMed     Abstract available
    
    
    
39. BARBARA R, Abdelaal AM, Levy R, Nagy A, et al
    Pediatric Eyelid Cutaneous Horns: A Case Series and Literature Review.
    Am J Ophthalmol. 2024 Oct 9:S0002-9394(24)00465.
    PubMed     Abstract available
    
    
    September 2024
40. RAMING K, Pfau M, Herrmann P, Holz FG, et al
    Anti-VEGF Treatment for Secondary Neovascularization in Pseudoxanthoma Elasticum - Age of Onset, Treatment Frequency, and Visual Outcome.
    Am J Ophthalmol. 2024;265:127-136.
    PubMed     Abstract available
    
    
    August 2024
41. LEE MY, Han K, Min KH, Yu DS, et al
    Psoriasis as a Predictor of Neovascular Age-Related Macular Degeneration in Type 2 Diabetes Mellitus: A Nationwide Cohort Study.
    Am J Ophthalmol. 2024 Aug 30:S0002-9394(24)00395.
    PubMed     Abstract available
    
    
    
42. VEMPULURU VS, Tanna V, Luthra A, Kaliki S, et al
    Eyelid/Periocular Sebaceous Gland Carcinoma in 500 Eyes: Analysis based on 8(th) Edition American Joint Cancer Committee Classification.
    Am J Ophthalmol. 2024 Aug 3:S0002-9394(24)00350.
    PubMed     Abstract available
    
    
    July 2024
43. JUNG H, Kim S, Lee CS, Byeon SH, et al
    Real-world incidence of incident noninfectious uveitis in patients treated with BRAF inhibitors: a nationwide clinical cohort study.
    Am J Ophthalmol. 2024 Jul 6:S0002-9394(24)00300.
    PubMed     Abstract available
    
    
    May 2024
44. KOJIMA M, Mieno H, Ueta M, Nakata M, et al
    Improvement of the Ocular Prognosis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A National Survey in Japan.
    Am J Ophthalmol. 2024 May 23:S0002-9394(24)00212.
    PubMed     Abstract available
    
    
    
45. WYLEGALA A, Pajak J, Wylegala E
    Bilateral Corneal and Conjunctival Melanosis.
    Am J Ophthalmol. 2024 May 17:S0002-9394(24)00206.
    PubMed    
    
    
    November 2023
46. CHOUDHRY HS, Patel AM, Nguyen HN, Kaleem MA, et al
    Significance of Social Determinants of Health in Tumor Presentation, Hospital Readmission, and Overall Survival in Ocular Oncology.
    Am J Ophthalmol. 2023 Nov 11:S0002-9394(23)00455.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum